![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, September 29, 2017 2:07:12 PM
Based on the number of outstanding shares and the value of competitors a fair market range for the stock with no sales but a viable working product without FDA approval is the 1.00 to 1.20 range. With FDA approval that would go to 3-4 dollars.
Thats why it is important for those invested at higher price to price average when the stock is low. Always investing just like gambling not over your head and with money that if your entire investment disappears it will not affect you significantly.
I am a surgeon working with the intuitive robot and would say that intuitive was not very customer friendly to surgeons and many surgeons would love to use another companies product.
Whether that will be titan's time will tell.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM